About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Philadelphia | 632 Studies

Clinical Trials Breast CancerPhiladelphia

Breast Cancer Clinical Trials in Philadelphia

Find 632 clinical trials for breast cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 561-580 of 632 trials

CompletedPilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast CancerThe central goal of this study is to examine the feasibility, acceptability, and preliminary efficacy of the IE intervention on patient and partner sexual QOL and relationship…NCT02721147·Philadelphia, Pennsylvania RecruitingIdentification of Breast Cancer in Breath Samples Using Trained Detection DogsThe goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath.NCT07038785·Totowa, New Jersey and 5 others RecruitingLong-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast CancerPatients with a germline pathogenic variant (GPV) in high-penetrance breast cancer susceptibility genes who are considering risk reducing mastectomy (RRM) often strongly desire to…NCT06888388·New Haven, Connecticut and 15 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsThis is a Phase 1 dose-escalation study of PRT3645, a Cyclin-dependent Kinase 4/6 (CDK4/6) inhibitor, in patients with advanced or metastatic solid tumors.NCT05538572·New Haven, Connecticut and 12 others

RecruitingA Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerThis study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with…NCT05894239·Gilbert, Arizona and 191 others

CompletedCryoablation of Low Risk Small Breast Cancer- ICE3 TrialTo evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .NCT02200705·Glendale, Arizona and 18 others

Active not recruitingNiraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerThe human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival.NCT03368729·Birmingham, Alabama and 6 others

TerminatedFlexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast CancerRATIONALE: The Flexitouch lymphedema system may lessen lymphedema caused by treatment for breast cancer.NCT01019512·Philadelphia, Pennsylvania

RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsThe goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to…NCT06586957·Little Rock, Arkansas and 19 others

CompletedStudy of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast CancerThe purpose of the study was to evaluate the safety and efficacy of a reduced ribociclib starting dose of 400 mg in combination with a non-steroidal aromatase inhibitor (NSAI)…NCT03822468·Mobile, Alabama and 88 others

TerminatedContinued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab AloneThis was a randomized, open-label, multi-center Phase III study evaluating the efficacy and safety of lapatinib in combination with trastuzumab versus trastuzumab alone as…NCT00968968·Chandler, Arizona and 115 others

Active not recruitingStudying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationThis phase III trial compares denosumab to placebo for the prevention of breast cancer in women with a BRCA1 germline mutation.NCT04711109·Los Angeles, California and 46 others

CompletedBreast Ultrasound and Mammography in Screening Women at High Risk for Breast CancerRATIONALE: Screening tests such as ultrasound and mammography may help doctors detect cancer cells early and plan more effective treatment for breast cancer.NCT00072501·Los Angeles, California and 19 others

Active not recruitingHypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerThis randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone…NCT03414970·Anchorage, Alaska and 858 others

CompletedGene Therapy Plus Chemotherapy in Treating Patients With Breast CancerPhase I trial to study the effectiveness of gene therapy plus chemotherapy in treating patients who have breast cancer.NCT00004038·Philadelphia, Pennsylvania

TerminatedA Study Of PF-06263507 In Patients With Advanced Solid TumorsTo assess the safety and tolerability at increasing dose levels of PF-06263507 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select…NCT01891669·Boston, Massachusetts and 3 others

CompletedMagnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast CancerRATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan…NCT00043017·Birmingham, Alabama and 10 others

CompletedThe Effect of Self-Management Interventions Among Patients With Breast Cancer Related-LymphedemaTo manage lymphedema, it's important to be aware of symptoms and risk factors, evaluate the afflicted extremity, prevent infections, care for the skin, protect the extremity from…NCT07803549·Amman, Amman Governorate

TerminatedEvaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid TumorsThe objective of this study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of BL-M17D1 in patients with HER2-Expressing or HER2-Mutant Advanced or Metastatic…NCT06714617·Denver, Colorado and 8 others

RecruitingPENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerThis is a single center, prospective cross-sectional study of women who have completed therapy for primary breast cancer within 5 years of diagnosis and are at increased risk for…NCT02732171·Philadelphia, Pennsylvania

PreviousPage 29 of 32Next

Other Conditions in Philadelphia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma